Donnez, J.; Donnez, O.; Tourniaire, J.; Brethous, M.; Bestel, E.; Garner, E.; Charpentier, S.; Humberstone, A.; Loumaye, E.
Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. J. Clin. Med. 2021, 10, 5794.
https://doi.org/10.3390/jcm10245794
AMA Style
Donnez J, Donnez O, Tourniaire J, Brethous M, Bestel E, Garner E, Charpentier S, Humberstone A, Loumaye E.
Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. Journal of Clinical Medicine. 2021; 10(24):5794.
https://doi.org/10.3390/jcm10245794
Chicago/Turabian Style
Donnez, Jacques, Olivier Donnez, Jean Tourniaire, Michel Brethous, Elke Bestel, Elizabeth Garner, Sébastien Charpentier, Andrew Humberstone, and Ernest Loumaye.
2021. "Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration" Journal of Clinical Medicine 10, no. 24: 5794.
https://doi.org/10.3390/jcm10245794
APA Style
Donnez, J., Donnez, O., Tourniaire, J., Brethous, M., Bestel, E., Garner, E., Charpentier, S., Humberstone, A., & Loumaye, E.
(2021). Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. Journal of Clinical Medicine, 10(24), 5794.
https://doi.org/10.3390/jcm10245794
